Wen-Xing Ding, PhD

Department of Pharmacology, Toxicology and Therapeutics, Director of Histopathology Core,
The University of Kansas Medical Center

Dr. Wen-Xing Ding currently is a professor of Department of Pharmacology, Toxicology and Therapeutics at The University of Kansas Medical Center. He received his Ph.D. from the National University of Singapore in 2002. He did his Postdoctoral training at University of Pittsburgh. In the past decade, Dr. Ding’s research has been focused on the molecular mechanisms of cell death and autophagy in liver diseases. Dr. Ding is an Associate Editor for Autophagy and editorial board member of Hepatology. Dr. Ding is a member of American Association of Studies of Liver Disease (AASLD), Society of Toxicology (SOT) and Research society of Alcoholism. Dr. Ding is also the Program Committee member of the American Society of Investigative Pathology (ASIP). Dr. Ding has published more than 100 papers in peer-reviewed journals and his research work is currently supported by NIAAA and NIDDK.

Dr. Ding’s current research focuses on the mechanisms of how autophagy protects against alcohol and drug-induced liver injury as well as non-alcoholic fatty liver disease. In particular, they are interested in identifying how autophagy selectively removes cellular damaged proteins and organelles such as mitochondria, lipid droplets and endoplasmic reticulum from hepatocytes. The ultimate goal of his research work is to develop novel approaches to modulate autophagy to treat liver diseases.